Literature DB >> 16355385

Endoscopic CO2 laser surgery for early glottic cancer in patients who are candidates for radiotherapy: results of a prospective nonrandomized study.

Mohssen Ansarin1, Michal Zabrodsky, Livia Bianchi, Giuseppe Renne, Antonella Tosoni, Luca Calabrese, Paola Tredici, Barbara A Jereczek-Fossa, Roberto Orecchia, Fausto Chiesa.   

Abstract

BACKGROUND: Treatment of early glottic malignancies is controversial, particularly if postoperative endoscopy shows minimal/no residual disease.
METHODS: In a prospective nonrandomized study, we performed endoscopic laser surgery with curative intent in 59 patients with early glottic carcinoma presenting for radiotherapy after diagnosis elsewhere by random biopsy or cordal stripping. We analyzed outcomes and residual cancer in the specimen.
RESULTS: Clinical staging elsewhere did not correspond to (usually underestimated) the pathologic stage in 60.7%. In 22%, no tumor was identified on pathologic examination. After 35.3 months (mean), 93.2% were alive with no evidence of disease. Local control was achieved in 98.3% of the patients, and 13.5% of the patients required radiotherapy. The larynx was conserved in 98.3%.
CONCLUSIONS: Biopsy/stripping are best abandoned for persistent glottic lesions. A single laser endoscopic procedure provides reliable staging and definitive treatment in most cases using fewer resources. Biopsied patients presenting for treatment should be offered laser surgery as an alternative to radiotherapy. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16355385     DOI: 10.1002/hed.20301

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Glottic laser surgery: outcomes according to 2007 ELS classification.

Authors:  Marco Lucioni; Gino Marioni; Andy Bertolin; Luciano Giacomelli; Giuseppe Rizzotto
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-19       Impact factor: 2.503

2.  Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population.

Authors:  Nicola Dinapoli; Claudio Parrilla; Jacopo Galli; Rosa Autorino; Francesco Miccichè; Francesco Bussu; Mario Balducci; Lucia D'Alatri; Raffaella Marchese; Mario Rigante; Giuseppe Di Lella; Luca Liberati; Giovanni Almadori; Gaetano Paludetti; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

3.  [Surgical treatment options in laryngeal and hypopharyngeal cancer].

Authors:  Hans E Eckel; Ursula Schröder; Markus Jungehülsing; Orlando Guntinas-Lichius; Michael Markitz; Wolfgang Raunik
Journal:  Wien Med Wochenschr       Date:  2008

4.  Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice.

Authors:  A J Remmelts; F J P Hoebers; W M C Klop; A J M Balm; O Hamming-Vrieze; M W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

5.  Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.

Authors:  You-Ping Liu; Xing Lv; Xiong Zou; Yi-Jun Hua; Rui You; Qi Yang; Le Xia; Shao-Yan Guo; Wen Hu; Meng-Xia Zhang; Si-Yuan Chen; Mei Lin; Yu-Long Xie; Li-Zhi Liu; Rui Sun; Pei-Yu Huang; Wei Fan; Xiang Guo; Ming-Huang Hong; Ming-Yuan Chen
Journal:  Cancer Commun (Lond)       Date:  2019-11-15

6.  Organ preservation and oncological outcomes in early laryngeal cancer: a propensity score-based study.

Authors:  Genival Barbosa de Carvalho; Hugo Fontan Kohler; Julia Bette Homem de Mello; Renan Bezerra Lira; Antonio Cássio de Assis Pellizzon; José Guilherme Vartanian; Luiz Paulo Kowalski
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-08       Impact factor: 2.124

7.  Oncological and functional outcome after surgical treatment of early glottic carcinoma without anterior commissure involvement.

Authors:  Jovica Milovanovic; Ana Jotic; Vojko Djukic; Bojan Pavlovic; Aleksandar Trivic; Sanja Krejovic-Trivic; Andjela Milovanovic; Aleksandar Milovanovic; Vera Artiko; Bojan Banko
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.